IRADIMED CORPORATION Statistics
Total Valuation
IRMD has a market cap or net worth of $903.12 million. The enterprise value is $850.12 million.
| Market Cap | 903.12M |
| Enterprise Value | 850.12M |
Important Dates
The last earnings date was Friday, August 1, 2025, before market open.
| Earnings Date | Aug 1, 2025 |
| Ex-Dividend Date | Aug 18, 2025 |
Share Statistics
IRMD has 12.72 million shares outstanding. The number of shares has increased by 0.59% in one year.
| Current Share Class | 12.72M |
| Shares Outstanding | 12.72M |
| Shares Change (YoY) | +0.59% |
| Shares Change (QoQ) | +0.08% |
| Owned by Insiders (%) | 36.76% |
| Owned by Institutions (%) | 48.11% |
| Float | 7.17M |
Valuation Ratios
The trailing PE ratio is 44.10 and the forward PE ratio is 41.76.
| PE Ratio | 44.10 |
| Forward PE | 41.76 |
| PS Ratio | 11.61 |
| Forward PS | 14.05 |
| PB Ratio | 9.58 |
| P/TBV Ratio | 9.93 |
| P/FCF Ratio | 63.57 |
| P/OCF Ratio | 33.27 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 34.55, with an EV/FCF ratio of 59.84.
| EV / Earnings | 41.15 |
| EV / Sales | 10.95 |
| EV / EBITDA | 34.55 |
| EV / EBIT | 35.71 |
| EV / FCF | 59.84 |
Financial Position
The company has a current ratio of 8.78
| Current Ratio | 8.78 |
| Quick Ratio | 7.25 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 23.75% and return on invested capital (ROIC) is 17.07%.
| Return on Equity (ROE) | 23.75% |
| Return on Assets (ROA) | 15.15% |
| Return on Invested Capital (ROIC) | 17.07% |
| Return on Capital Employed (ROCE) | 24.39% |
| Revenue Per Employee | $485,220 |
| Profits Per Employee | $129,110 |
| Employee Count | 160 |
| Asset Turnover | 0.79 |
| Inventory Turnover | 1.54 |
Taxes
In the past 12 months, IRMD has paid $5.38 million in taxes.
| Income Tax | 5.38M |
| Effective Tax Rate | 20.66% |
Stock Price Statistics
The stock price has increased by +62.34% in the last 52 weeks. The beta is 0.95, so IRMD's price volatility has been similar to the market average.
| Beta (5Y) | 0.95 |
| 52-Week Price Change | +62.34% |
| 50-Day Moving Average | 60.91 |
| 200-Day Moving Average | 55.97 |
| Relative Strength Index (RSI) | 70.14 |
| Average Volume (20 Days) | 53,013 |
Short Selling Information
The latest short interest is 212,129, so 1.67% of the outstanding shares have been sold short.
| Short Interest | 212,129 |
| Short Previous Month | 227,164 |
| Short % of Shares Out | 1.67% |
| Short % of Float | 2.96% |
| Short Ratio (days to cover) | 4.48 |
Income Statement
In the last 12 months, IRMD had revenue of $77.64 million and earned $20.66 million in profits. Earnings per share was $1.61.
| Revenue | 77.64M |
| Gross Profit | 59.75M |
| Operating Income | 23.81M |
| Pretax Income | 23.60M |
| Net Income | 20.66M |
| EBITDA | 24.60M |
| EBIT | 23.81M |
| Earnings Per Share (EPS) | $1.61 |
Balance Sheet
The company has $53.00 million in cash and n/a in debt, giving a net cash position of $53.00 million or $4.17 per share.
| Cash & Cash Equivalents | 53.00M |
| Total Debt | n/a |
| Net Cash | 53.00M |
| Net Cash Per Share | $4.17 |
| Equity (Book Value) | 94.30M |
| Book Value Per Share | 7.41 |
| Working Capital | 68.56M |
Cash Flow
In the last 12 months, operating cash flow was $27.14 million and capital expenditures -$12.93 million, giving a free cash flow of $14.21 million.
| Operating Cash Flow | 27.14M |
| Capital Expenditures | -12.93M |
| Free Cash Flow | 14.21M |
| FCF Per Share | $1.12 |
Margins
Gross margin is 76.96%, with operating and profit margins of 30.67% and 26.61%.
| Gross Margin | 76.96% |
| Operating Margin | 30.67% |
| Pretax Margin | 33.54% |
| Profit Margin | 26.61% |
| EBITDA Margin | 31.69% |
| EBIT Margin | 30.67% |
| FCF Margin | 18.30% |
Dividends & Yields
This stock pays an annual dividend of $0.68, which amounts to a dividend yield of 0.96%.
| Dividend Per Share | $0.68 |
| Dividend Yield | 0.96% |
| Dividend Growth (YoY) | -29.03% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 41.00% |
| Buyback Yield | -0.59% |
| Shareholder Yield | 0.34% |
| Earnings Yield | 2.29% |
| FCF Yield | 1.57% |
Analyst Forecast
The average price target for IRMD is $72.00, which is 0.80% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $72.00 |
| Price Target Difference | 0.80% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
IRMD has an Altman Z-Score of 35.88 and a Piotroski F-Score of 4.
| Altman Z-Score | 35.88 |
| Piotroski F-Score | 4 |